CJC-1295 (No DAC) + Ipamorelin

CJC-1295 (No DAC) + Ipamorelin

CJC-1295 (No DAC) and Ipamorelin are synthetic peptides studied in laboratory research involving growth hormone signaling, receptor activity, and endocrine regulation.

CJC-1295 (No DAC), often referred to as Modified GRF (1-29), is a growth hormone-releasing hormone (GHRH) analog investigated for its interactions with GHRH receptors. Ipamorelin is a selective growth hormone secretagogue studied for its activity at the ghrelin receptor (GHS-R1a).

Together, these peptides are of scientific interest in experimental models examining different signaling pathways associated with growth hormone release.

Research Areas of Interest:

• Growth Hormone Signaling: Investigated for interactions with pathways involved in growth hormone secretion and regulation.

• Receptor Activity: Studied for their respective interactions with GHRH and ghrelin receptors.

• Endocrine Research: Explored in experimental models examining hormonal signaling and feedback mechanisms.

• Peptide Interactions: Investigated for the combined effects of distinct peptide signaling mechanisms.

Product Information:

• Compounds: CJC-1295 (No DAC) + Ipamorelin

• Classification: Synthetic Research Peptide Blend

• Intended Use: Laboratory Research Only

Research Use Disclaimer:

This product is intended strictly for laboratory research purposes. Not for human or veterinary use, consumption, or administration. Not intended to diagnose, treat, cure, or prevent any disease.